Literature DB >> 8748273

Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata.

M A Pfaller1, A Houston, S Coffmann.   

Abstract

CHROMagar Candida is a new differential culture medium that allows selective isolation of yeasts and simultaneously identifies colonies of Candida albicans, C. tropicalis, and C. krusei. We evaluated the use of this medium with 316 yeast isolates including 247 isolated directly on CHROMagar from clinical material. Over 95% of stock and clinical isolates of C. albicans, C. tropicalis, and C. krusei were correctly identified on the basis of colony morphology and pigmentation on CHROMagar. Additionally, CHROMagar also allowed the identification of C. (Torulopsis) glabrata at a similar level of accuracy. The overall agreement between two observers in reading the CHROMagar plates was 95%. Growth of Candida sp. isolates on CHROMagar had no adverse effect on antifungal MICs or Vitek identification results. In parallel, cultures of 548 stool and rectal swab specimens set up on CHROMagar and Sabouraud glucose agar (SGA) were positive in 234 instances. CHROMagar was positive and SGA was negative for 11 specimens, and CHROMagar was negative and SGA was positive for 18 specimens. A single yeast species was isolated on both media from 162 specimens, and in 146 (90%) of these specimens the same species was detected on both CHROMagar and SGA. A total of 43 of the 234 positive cultures contained mixtures of yeast species. Twenty (47%) of these mixed cultures were detected only on CHROMagar. CHROMagar is extremely useful in making a rapid presumptive identification of common yeast species. This capability plus the ability to detect mixed cultures of Candida spp. promises to improve and streamline the work flow in the mycology and clinical microbiology laboratory.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8748273      PMCID: PMC228730          DOI: 10.1128/jcm.34.1.58-61.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  Comparison of visual and spectrophotometric methods of MIC endpoint determinations by using broth microdilution methods to test five antifungal agents, including the new triazole D0870.

Authors:  M A Pfaller; S A Messer; S Coffmann
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

2.  Predictive value of surveillance cultures for systemic infection due to Candida species.

Authors:  M Pfaller; I Cabezudo; F Koontz; M Bale; R Gingrich
Journal:  Eur J Clin Microbiol       Date:  1987-12       Impact factor: 3.267

3.  Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe.

Authors:  D R Reagan; M A Pfaller; R J Hollis; R P Wenzel
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

4.  The value of fungal surveillance cultures as predictors of systemic fungal infections.

Authors:  G R Sandford; W G Merz; J R Wingard; P Charache; R Saral
Journal:  J Infect Dis       Date:  1980-10       Impact factor: 5.226

5.  Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group.

Authors:  J H Rex; M A Pfaller; A L Barry; P W Nelson; C D Webb
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

6.  Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period.

Authors:  M F Price; M T LaRocco; L O Gentry
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

7.  Comparison of the Quantum II, API Yeast Ident, and AutoMicrobic systems for identification of clinical yeast isolates.

Authors:  M A Pfaller; T Preston; M Bale; F P Koontz; B A Body
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

8.  Investigation of the sequence of colonization and candidemia in nonneutropenic patients.

Authors:  A Voss; R J Hollis; M A Pfaller; R P Wenzel; B N Doebbeling
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

Review 9.  Importance of Candida species other than C. albicans as pathogens in oncology patients.

Authors:  J R Wingard
Journal:  Clin Infect Dis       Date:  1995-01       Impact factor: 9.079

10.  CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species.

Authors:  F C Odds; R Bernaerts
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

View more
  72 in total

Review 1.  The ins and outs of DNA fingerprinting the infectious fungi.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

2.  Cost-effective and rapid presumptive identification of gram-negative bacilli in routine urine, pus, and stool cultures: evaluation of the use of CHROMagar orientation medium in conjunction with simple biochemical tests.

Authors:  K Ohkusu
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

3.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

4.  In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrata.

Authors:  E R Oliveira; A W Fothergill; W R Kirkpatrick; B J Coco; T F Patterson; S W Redding
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

5.  Evaluation of a reformulated CHROMagar Candida.

Authors:  M A Jabra-Rizk; T M Brenner; M Romagnoli; A A Baqui; W G Merz; W A Falkler; T F Meiller
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

6.  Rapid and accurate identification of Candida albicans isolates by use of PNA FISHFlow.

Authors:  Jan Trnovsky; William Merz; Phyllis Della-Latta; Fann Wu; Maiken Cavling Arendrup; Henrik Stender
Journal:  J Clin Microbiol       Date:  2008-02-20       Impact factor: 5.948

7.  Evaluation of CHROMagar Candida plates.

Authors:  A M Freydiere
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

8.  Comparison of a new chromogenic agar with the germ tube method for presumptive identification of Candida albicans.

Authors:  C K Campbell; A D Holmes; K G Davey; A Szekely; D W Warnock
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-05       Impact factor: 3.267

9.  CHROMagar Candida as the sole primary medium for isolation of yeasts and as a source medium for the rapid-assimilation-of-trehalose test.

Authors:  Melissa P Murray; Riva Zinchuk; Davise H Larone
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

10.  Identification of Candida albicans and Candida glabrata within 1.5 hours directly from positive blood culture bottles with a shortened peptide nucleic acid fluorescence in situ hybridization protocol.

Authors:  Michael Gherna; William G Merz
Journal:  J Clin Microbiol       Date:  2008-11-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.